{"DataElement":{"publicId":"2328","version":"3","preferredName":"Measurable Disease Present Ind-3","preferredDefinition":"a yes/no indicator that asks whether measurable disease is present.","longName":"MSRBL_DZ_PRES_IND-3","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2189049","version":"1","preferredName":"Measurable Disease Present","preferredDefinition":"information related to measurable disease being present.","longName":"MSRBL_DZ_PRES","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206631","version":"1","preferredName":"Measurable Diseases and Disorders","preferredDefinition":"Capable of being measured.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C37894:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable","conceptCode":"C37894","definition":"Capable of being measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FD6A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177376","version":"1","preferredName":"Present","preferredDefinition":"Present; the period of time that is happening now.","longName":"Present","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5263-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5DE5293-C6DB-125A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506034","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"YES_NO_UNKNOWN_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D05-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D0F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D1A-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548260","version":"1","preferredName":"Ind-3","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no/unknown.","longName":"C38148","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Unknown Response","conceptCode":"C38148","definition":"A response or indicator that can have a value of yes, no, or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"23801A33-5B13-534B-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2006-11-30","endDate":"2016-04-27","createdBy":"BIRNBAUA","dateCreated":"2006-11-30","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 4-27-2016 per Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6CF1-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TITARENI","dateModified":"2021-09-14","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/35/2016 jk removed \"indeterminate\" value that was added in error. 7/7/2021wz: added ALT VM name for HOPE-CARE project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"},{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"2812017","version":"1","longName":"Phase II Lung Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811962","version":"1","longName":"Response","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812015","version":"1","longName":"Metastatic Brain","context":"CTEP"},{"publicId":"2812013","version":"1","longName":"Primary Brain New","context":"CTEP"},{"publicId":"2812014","version":"1","longName":"Primary Brain Recurr","context":"CTEP"},{"publicId":"2811920","version":"1","longName":"Non-local Prostate","context":"CTEP"},{"publicId":"2811810","version":"1","longName":"NSCLC 2nd Line","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"},{"publicId":"2811821","version":"1","longName":"SCLC 2nd Line","context":"CTEP"},{"publicId":"2811822","version":"1","longName":"SCLC Extensive","context":"CTEP"},{"publicId":"2811823","version":"1","longName":"SCLC Limited","context":"CTEP"},{"publicId":"2811931","version":"1","longName":"NSCLC Stage I-III","context":"CTEP"},{"publicId":"2811819","version":"1","longName":"Primary Ovarian","context":"CTEP"},{"publicId":"2811934","version":"1","longName":"Pathology Gyn","context":"CTEP"},{"publicId":"2811938","version":"1","longName":"Recurrent Gyn","context":"CTEP"},{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"},{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"2964591","version":"1","longName":"Eligibility Criteria","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2965104","version":"1","longName":"Structured Eligibility Criteria","context":"NCIP"},{"publicId":"3070842","version":"1","longName":"Diagnosis","context":"NCIP"}]},{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]},{"publicId":"3335728","version":"1","longName":"Protocols","context":"ABTC","ClassificationSchemeItems":[{"publicId":"3335732","version":"1","longName":"ABTC 0904","context":"ABTC"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104888","version":"1","longName":"GOG-0209","context":"NRG"},{"publicId":"4104896","version":"1","longName":"GOG-0249","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"4104933","version":"1","longName":"RTOG-1308","context":"NRG"},{"publicId":"4104898","version":"1","longName":"GOG-0258","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"},{"publicId":"4104900","version":"1","longName":"GOG-0277","context":"NRG"}]}],"AlternateNames":[{"name":"0002654","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0064830","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0000974","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0065152","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0002187","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0062996","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"MSRBL_DZ_PRES_IND-3","type":"C3D Name","context":"NCIP"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"GOG","type":"USED_BY","context":"NRG"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"PtMeasDiseaseDocbyRadF","type":"COG GDE Short Name","context":"CTEP"},{"name":"MSRBL_DZ_PRES_IND-3","type":"USED_BY","context":"NRG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"MSRBL_DZ_PRES_IND-3","type":"USED_BY","context":"Alliance"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"TR_TRYN_TMR","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Does the patient have measurable disease","url":null,"context":"CTEP"},{"name":"Is measurable disease present?","type":"Preferred Question Text","description":"Is measurable disease present?","url":null,"context":"CTEP"},{"name":"1-COMMENT","type":"COMMENT","description":"Add instruction to template form: (only applicable in studies where there is residual disease at baseline)","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Measurable?","url":null,"context":"NCIP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Does the patient have measurable disease defined as at least one lesion that can be accurately measured in at least one dimension","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Measurable disease as defined in Section 11.0","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Radiologically measurable or clinically evaluable disease as defined in section 11.0","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Was measurable disease present","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Measurable disease","url":null,"context":"CTEP"},{"name":"GOG_CRF Text","type":"Alternate Question Text","description":"Was the recurrence of disease documented by clinically evident measurable disease?","url":null,"context":"NRG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does patient have measurable disease documented by radiographic findings?","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Does patient have measurable disease documented by clinical, radiographic, or histologic criteria?","url":null,"context":"COG"},{"name":"ALT 2","type":"Alternate Question Text","description":"Does the patient have measurable disease as defined by the protocol?","url":null,"context":"ECOG-ACRIN"},{"name":"ALT 1","type":"Alternate Question Text","description":"Does the patient have measurable disease (by RECIST 1.1 criteria) or non-measurable and present in at least one non-liver site, 1.5 cm or greater and visualized on PET/CT with [18F]-fluorodeoxyglucose (FDG)?","url":null,"context":"ECOG-ACRIN"},{"name":"EAI142 Text","type":"Alternate Question Text","description":"Does the patient have measurable disease (by RECIST 1.1 criteria) or non-measurable and present in at least one non-liver site, where presence is defined as 1.5 cm or greater and visualized on PET/CT with [18F]-fluorodeoxyglucose (FDG)?","url":null,"context":"ECOG-ACRIN"},{"name":"CRF_Text_2","type":"Alternate Question Text","description":"Does the patient have measurable disease as defined by RECIST 1.1","url":null,"context":"CTEP"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Could metastatic disease be measured?","url":null,"context":"COG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Does patient have radiographically measurable disease?","url":null,"context":"COG"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Is this lesion measurable by RECIST?","url":null,"context":"Alliance"},{"name":"CRF Text 10","type":"Alternate Question Text","description":"Evaluable or measurable disease outside the CNS","url":null,"context":"CTEP"},{"name":"EA1142_2","type":"Alternate Question Text","description":"Does the patient have measurable disease (by RECIST 1.1 criteria) or non-measurable and present in at least one non-liver site, where presence is defined as 1.5 cm or greater and documented by biopsy or at least two imaging methods?","url":null,"context":"ECOG-ACRIN"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"Does the patient have evidence of measurable disease outside of the radiation field at the time of registration?","url":null,"context":"CTEP"},{"name":"CRF Text14","type":"Alternate Question Text","description":"Did the patient have intracranial measurable disease at baseline?","url":null,"context":"Alliance"},{"name":"CRF Text13","type":"Alternate Question Text","description":"New measureable disease","url":null,"context":"Alliance"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Measureable CNS disease","url":null,"context":"Alliance"},{"name":"CRF Text15","type":"Alternate Question Text","description":"Is the measureable disease restricted to a solitary lesion?","url":null,"context":"Alliance"},{"name":"CRF Text16","type":"Alternate Question Text","description":"Does the participant have measurable disease?","url":null,"context":"Alliance"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Does the patient have RECIST 1.1 measurable disease?","url":null,"context":"NRG"},{"name":"EAI142_2","type":"Alternate Question Text","description":"Does the patient have measurable disease (by RECIST 1.1 criteria) and is 1.5 cm or greater in longest dimension OR non-measurable disease that is 1.5 cm or greater in longest dimension?","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Does the patient have measurable disease as defined by RECIST 1.1?","url":null,"context":"COG"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"For patients who had no measurable disease at enrollment, has the patient developed measurable or evaluable disease since enrollment?","url":null,"context":"COG"},{"name":"CRF Text 17","type":"Alternate Question Text","description":"Does the patient have evaluable disease (defined as RECIST 1.1 measurable disease) OR non-measurable disease (defined as solid and/or cystic abnormalities on radiographic imaging that do not meet RECIST 1.1 definitions for target lesions OR ascites and/or pleural effusion that has been pathologically demonstrated to be disease-related in the setting of a CA125 equal to or greater than 2x upper limit of normal (ULN))?","url":null,"context":"NRG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Does patient have measurable disease, documented by radiographic imaging per LCH-specific RECIST/PERSIST criteria?","url":null,"context":"COG"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Does the patient have evaluable disease or measurable disease?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does the patient have measurable disease?","url":null,"context":"NRG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Were new measurable lesions identified in this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Were new non-measurable lesions identified in this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Were new measurable lesions identified?","url":null,"context":"COG"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Were target lesions/measurable lesions identified?","url":null,"context":"COG"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Were new target lesions identified in this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 45","type":"Alternate Question Text","description":"Does patient have measurable disease, documented by radiographic imaging per LCH-specific response criteria?","url":null,"context":"COG"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Does the patient have measurable disease according to RECIST v1.1?","url":null,"context":"NRG"},{"name":"Alliance - 1","type":"Alternate Question Text","description":"Measurable disease per RECIST v1.1?","url":null,"context":"Alliance"},{"name":"NRG CRF_Text_3","type":"Alternate Question Text","description":"Does the patient have measurable and biopsiable disease?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_4","type":"Alternate Question Text","description":"Does the patient have measurable disease based on RECIST 1.1?","url":null,"context":"NRG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Longest dimension of Invasive Carcinoma available?","url":null,"context":"CCTG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B2D02DCA-9FE8-720C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"CLOHNES","dateModified":"2023-11-08","changeDescription":"Replaced VD Disease Ind-3 (2018305v1) with VD Yes No Unknown Indicator (3506034v1) - dw","administrativeNotes":"11/08/23 Added AQT and alt OID for CCTG ticket number CADSR0003018 cjl.: 2023.10.22 AQT added for ticket request CADSR0002989._mmt\r\n2022.12.20 AQT added for ticket request CADSR0001812. ak 2022.11.15 AQT added for ticket request CADSR0001687. ak","unresolvedIssues":null,"deletedIndicator":"No"}}